2nd Quarter - Report

VENN STRATEGIES for PHRMA

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to access to bio-pharmaceuticals.

LobbyistCovered position, as disclosed
NATASCHA CUMBERLIDGE —
PETER GOELZ —
MICHELLE SEGER —
STEPHANIE SILVERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.